Viking Therapeutics, Inc. ($VKTX)
Filing Information
| Accession Number | 0001193125-26-324447 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 30, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
52,884
Total Value
$710,141.48
P&L
+inf% (+$1,058,627.81)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock, par value $0.00001 per share | โ | Jul 28, 2026 | Grant/Award | 31,667 | $0.00 | $0.00 | 233,421 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock, par value $0.00001 per share | โ | Jul 29, 2026 | Sale | 21,217 | $33.47 | $710,141.48 | 212,204 | Direct | โ | View Details |